Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

MicroRNAs in normal and malignant hematopoiesis.

Garzon R, Croce CM.

Curr Opin Hematol. 2008 Jul;15(4):352-8. doi: 10.1097/MOH.0b013e328303e15d. Review.

PMID:
18536574
2.

The role of microRNAs in normal and malignant hematopoiesis.

Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J.

Eur J Haematol. 2010 Jan 1;84(1):1-16. doi: 10.1111/j.1600-0609.2009.01348.x. Review.

PMID:
19744129
3.

MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

Sonkoly E, Ståhle M, Pivarcsi A.

Semin Cancer Biol. 2008 Apr;18(2):131-40. doi: 10.1016/j.semcancer.2008.01.005. Review.

PMID:
18291670
4.

MicroRNAs in benign and malignant hematopoiesis.

Bhagavathi S, Czader M.

Arch Pathol Lab Med. 2010 Sep;134(9):1276-81. doi: 10.1043/2009-0178-RS.1. Review.

PMID:
20807046
5.

MicroRNAs and haematology: small molecules, big function.

Lawrie CH.

Br J Haematol. 2007 Jun;137(6):503-12. Review.

PMID:
17539773
6.

Potential therapeutic applications of miRNA-based technology in hematological malignancies.

Barbarotto E, Calin GA.

Curr Pharm Des. 2008;14(21):2040-50. Review.

PMID:
18691114
7.

MicroRNAs: emerging key regulators of hematopoiesis.

Havelange V, Garzon R.

Am J Hematol. 2010 Dec;85(12):935-42. doi: 10.1002/ajh.21863. Review.

8.

Adding fuel to fire: microRNAs as a new class of mediators of inflammation.

Sheedy FJ, O'Neill LA.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii50-5. doi: 10.1136/ard.2008.100289. Review.

PMID:
19022814
9.

MicroRNA gene expression in malignant lymphoproliferative disorders.

Xu W, Li JY.

Chin Med J (Engl). 2007 Jun 5;120(11):996-9. Review.

PMID:
17624268
10.

MicroRNAs in normal and malignant myelopoiesis.

Pelosi E, Labbaye C, Testa U.

Leuk Res. 2009 Dec;33(12):1584-93. doi: 10.1016/j.leukres.2009.04.039. Review.

PMID:
19482355
11.

MicroRNAs in the ontogeny of leukemias and lymphomas.

Fabbri M, Croce CM, Calin GA.

Leuk Lymphoma. 2009 Feb;50(2):160-70. doi: 10.1080/10428190802535114. Review.

PMID:
19160125
12.

The clinicopathological relevance of microRNA in normal and malignant haematopoiesis.

Bryant A, Lutherborrow M, Ma D.

Pathology. 2009;41(3):204-13. doi: 10.1080/00313020902756287. Review.

PMID:
19291531
13.

MicroRNAs, the immune system and rheumatic disease.

Tili E, Michaille JJ, Costinean S, Croce CM.

Nat Clin Pract Rheumatol. 2008 Oct;4(10):534-41. doi: 10.1038/ncprheum0885. Review.

PMID:
18728632
14.

MiR-125 in normal and malignant hematopoiesis.

Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S.

Leukemia. 2012 Sep;26(9):2011-8. doi: 10.1038/leu.2012.90. Review.

PMID:
22456625
15.

miR signatures and the role of miRs in acute myeloid leukaemia.

Seca H, Almeida GM, Guimarães JE, Vasconcelos MH.

Eur J Cancer. 2010 Jun;46(9):1520-7. doi: 10.1016/j.ejca.2010.03.031. Review.

PMID:
20413298
16.

MicroRNAs: key players of normal and malignant myelopoiesis.

Alemdehy MF, Erkeland SJ.

Curr Opin Hematol. 2012 Jul;19(4):261-7. doi: 10.1097/MOH.0b013e328353d4e9. Review.

PMID:
22504525
17.

MicroRNAs grow up in the immune system.

Hoefig KP, Heissmeyer V.

Curr Opin Immunol. 2008 Jun;20(3):281-7. doi: 10.1016/j.coi.2008.05.005. Review.

PMID:
18554884
18.

The role of microRNAs in normal hematopoiesis and hematopoietic malignancies.

Kluiver J, Kroesen BJ, Poppema S, van den Berg A.

Leukemia. 2006 Nov;20(11):1931-6. Review.

PMID:
16990772
19.

miR-21 as a key regulator of oncogenic processes.

Selcuklu SD, Donoghue MT, Spillane C.

Biochem Soc Trans. 2009 Aug;37(Pt 4):918-25. doi: 10.1042/BST0370918. Review.

PMID:
19614619
20.

MicroRNAs as regulators of mammalian hematopoiesis.

Chen CZ, Lodish HF.

Semin Immunol. 2005 Apr;17(2):155-65. Review.

PMID:
15737576
Items per page

Supplemental Content

Support Center